Recombinant Human ADAM17 protein (ab114186)

Overview

Description

  • NatureRecombinant
  • SourceWheat germ
  • Amino Acid Sequence
    • AccessionP78536
    • SpeciesHuman
    • SequenceRADPDPMKNTCKLLVVADHRFYRYMGRGEESTTTNYLIELIDRVDDIYRN TSWDNAGFKGYGIQIEQIRILKSPQEVKPGEKHYNMAKSYPNEEKDAWDV
    • Molecular weight37 kDa including tags
    • Amino acids215 to 314

Associated products

Specifications

Our Abpromise guarantee covers the use of ab114186 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    SDS-PAGE

    Western blot

    ELISA

  • FormLiquid
  • Additional notesProtein concentration is above or equal to 0.05 mg/ml.
    This protein is best used within three months from the date of receipt.
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.

    pH: 8.00
    Constituents: 0.3% Glutathione, 0.79% Tris HCl

General Info

  • Alternative names
    • A disintegrin and metalloproteinase domain 17
    • A disintegrin and metalloproteinase domain 17 (tumor necrosis factor, alpha, converting enzyme)
    • ADA17_HUMAN
    • ADAM 17
    • ADAM metallopeptidase domain 17
    • ADAM17
    • ADAM17 protein
    • CD 156b
    • CD156b
    • CD156b antigen
    • CSVP
    • Disintegrin and metalloproteinase domain-containing protein 17
    • MGC71942
    • NISBD
    • NISBD1
    • Snake venom like protease
    • Snake venom-like protease
    • TACE
    • TNF alpha convertase
    • TNF alpha converting enzyme
    • TNF-alpha convertase
    • TNF-alpha-converting enzyme
    • Tumor Necrosis Factor Alpha Converting Enzyme
    see all
  • FunctionCleaves the membrane-bound precursor of TNF-alpha to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface. Responsible for the proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein. Also involved in the activation of Notch pathway.
  • Tissue specificityUbiquitously expressed. Expressed at highest levels in adult heart, placenta, skeletal muscle, pancreas, spleen, thymus, prostate, testes, ovary and small intestine, and in fetal brain, lung, liver and kidney.
  • Sequence similaritiesContains 1 disintegrin domain.
    Contains 1 peptidase M12B domain.
  • DomainMust be membrane anchored to cleave the different substrates. The cytoplasmic domain is not required for the this activity. Only the catalytic domain is essential to shed TNF and p75 TNFR.
    The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.
  • Post-translational
    modifications
    The precursor is cleaved by a furin endopeptidase.
    Phosphorylated. Stimulation by growth factor or phorbol 12-myristate 13-acetate induces phosphorylation of Ser-819 but decreases phosphorylation of Ser-791.
  • Cellular localizationMembrane.
  • Information by UniProt

Recombinant Human ADAM17 protein images

  • ab114186 on a 12.5% SDS-PAGE Stained with Coomassie Blue.

References for Recombinant Human ADAM17 protein (ab114186)

ab114186 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab114186.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"